Matching articles for "April 21"
Issue 1284 · April 21, 2008
Which Statin?

Advertisements for atorvastatin (Lipitor) , the market leader facing generic competition, have been in the news recently in the US. Lovastatin, pravastatin and simvastatin are all available generically at a…

Med Lett Drugs Ther. 2008 Apr 21; 50(1284):29-31
Advertisements for atorvastatin (Lipitor) , the market leader facing generic competition, have been in the news recently in the US. Lovastatin, pravastatin and simvastatin are all available generically at a much lower retail price or lower co-pay than atorvastatin.
Issue 1284 · April 21, 2008
Diclofenac Gel For Osteoarthritis

The nonsteroidal anti-inflammatory drug (NSAID) diclofenac, has been approved by the FDA in a 1% topical gel formulation ( Voltaren Gel - Endo) for treatment of osteoarthritis (OA). A 3% topical diclofenac gel…

Med Lett Drugs Ther. 2008 Apr 21; 50(1284):31-2
The nonsteroidal anti-inflammatory drug (NSAID) diclofenac, has been approved by the FDA in a 1% topical gel formulation ( Voltaren Gel - Endo) for treatment of osteoarthritis (OA). A 3% topical diclofenac gel ( Solaraze ) is currently approved for treatment of actinic keratoses, but not for topical use on joints. No other topical NSAIDs are approved by the FDA for OA. A diclofenac patch ( Flector ) was recently approved by the FDA for treatment of pain due to minor strains, sprains and contusions.
Issue 1284 · April 21, 2008 Free
In Brief: Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome

Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome Carbamazepine ( Tegretol, Carbatrol, Equetro , and others), which is now used to treat not only epilepsy but also trigeminal neuralgia and manic…

Med Lett Drugs Ther. 2008 Apr 21; 50(1284):29
Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome Carbamazepine ( Tegretol, Carbatrol, Equetro , and others), which is now used to treat not only epilepsy but also trigeminal neuralgia and manic episodes in patients with bipolar disorder, 1 is a known cause of Stevens-Johnson syndrome (SJS). The incidence of carbamazepine-induced SJS in countries with mainly white populations is 1 to 6 per 10,000 new users of the drug, but Asian patients have a 10-fold higher incidence of this reaction. An association has been found between the human leukocyte antigen (HLA)-B*1502 allele and carbamazepine-induced SJS in a Chinese population. 2 This allele occurs almost exclusively in Asians. 3,4 The FDA is now recommending that Asian patients be tested for genetic susceptibility to carbamazepine-induced SJS before starting the drug. The genetic test should be available in most clinical chemistry labs. 1. Extended-release carbamazepine (Equetro) for bipolar disorder. Med Lett Drugs Ther 2005; 47:27. 2. WH Chung et al. Medical genetics: a marker for Stevens- Johnson syndrome. Nature 2004; 428:486. 3. C Lonjou et al. A marker for Stevens-Johnson syndrome. . . : ethnicity matters. Pharmacogenomics J 2006; 6:265. 4. A Alfirevic et al. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 2006; 7:813. Download U.S. English